Screening and Characterization of Tetrahydrothiophene-3-one Reductase

YAN Yang,YU Huilei,PAN Jiang,XU Jianhe
DOI: https://doi.org/10.14135/j.cnki.1006-3080.20180122003
2019-01-01
Abstract:(R)-Tetrahydrothiophene-3-ol, a key intermediate of sulopenem (a novel 2-sulfanyl pennan compound, used for therapy of livestock bacterial diseases) has been highly desired for pharmaceutical use over the last three decades. Apart from the complicated and environment-consuming chemical synthesis, the most straightforward approach for this synthesis is the biological asymmetric reduction of tetrahydrothiophene-3-one. A high enantioselective ketoreductase is needed to achieve this reaction. However, it is difficult to screen a high enantioselective ketoreductase towards the nearly spatially symmetrical substrate, tetrahydrothiophene-3-one. Some research has explored this issue, but only resulted in mere enantiomeric excess (e.e.value), or long reaction time. Our research has explored a new enzyme (designated as BaCR1) from Bacillus anthracis str. Ames by library screening, which can be used for asymmetric synthesis of (R)-tetrahydrothiophene-3-ol. Its characteristics was furtherly investigated after protein purification by affinity adsorption separation with Ni-column. After performing reaction optimization, we found that its optimal pH and temperature for catalysis reaction was 7.0 and 30 °C respectively. The kcat/KM value was 0.25 s –1 * mmol/L –1 , using a substrate concentration range of 0.125 mmol/L–50 mmol/L. The half-life of purified BaCR1 was 9.63 h and 3.04 h at 30 o C and 40 o C, which showed the thermostability of BaCR1 in the catalysis progress. Finally, (R)-tetrahydrothiophene-3-ol was prepared in 100 mL scale. Without extra addition of NADPH, the reaction conversion could reach 99% with 84% e.e. (enantiomeric excess) at the substrate loading of 50 mmol/L. Considering that this is a nature parent enzyme, the result was reasonably understood, which illustrated the potential of enzyme-catalyzed asymmetric synthesis of (R)tetrahydrothiophen-3-ol.
What problem does this paper attempt to address?